Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... a measure to control for other symptoms that may covary with AVHs and for the effects of antipsychotic medication," wrote G. Modinos and colleagues, University of Groningen. The ...
2009 NOV 23 ... for serotonergic, alpha-adrenergic, and dopaminergic receptors, suggesting potential for antipsychotic and cognitive-enhancing properties. The effects of asenapine in rat models of...
2009 NOV 23 ... to calls for treating bipolar disorders in the primary care setting. Second-generation antipsychotic medications (SGAs) were initially lauded for treating bipolar disorders because of their ...
2009 NOV 23 ... prospective, observational study designed to assess costs and outcomes associated with antipsychotic use in outpatients initiating or changing antipsychotic ...
2009 NOV 23 ... journal Psychopharmacology report. "In this study, we examined whether the antipsychotic potential of mGlu2/3 receptor agonism can be enhanced with 5-HT2A receptor antagonism. ...
2009 NOV 23 ... symptoms resolving in most cases after completion of IFN therapy with or without antipsychotic treatment," wrote Y.C. Cheng and colleagues. The researchers concluded: ...
2009 NOV 23 ... (ID-ED) attentional set-shifting task." "The second generation antipsychotic, sertindole, provided further validation of the schizophrenia-like disease models. ...
2009 NOV 23 ... new data in the report 'Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.' "Negative symptoms ...
2009 NOV 23 ... studies have indicated that the more favorable illness course and the better response to antipsychotic drugs (APDs) in women with schizophrenia correlate with high levels of estrogen, whereas ...
2009 NOV 23 ... in some ambulant patients with psychoses/schizophrenia, especially if the brand atypical antipsychotic is substituted in the pharmacy without the acknowledgement of the patient and treating ...
2009 NOV 28 ... to recent research from Netherlands, "Rodents are usually used to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the ...
2009 NOV 23 ... by neuroleptics. The present study was designed to further investigate potential antipsychotic properties of 1MeTIQ by using both behavioral and neurochemical studies in the rat. We ...
2009 NOV 23 ... Psychiatry report. "The aim of the study was to assess the efficacy of the antipsychotic and mood-stabilizing agent olanzapine and the efficacy of the combination of an ...
2009 NOV 23 ... with psychotic disorders who use these services and who have problems adhering to antipsychotic depot medication, although all conventional methods to achieve adherence have been ...
2009 NOV 23 ... From 2003 to 2006, Beamish served as executive director, commercial operations for the antipsychotic drug Seroquel, leading the cross-functional team that took the brand to over $3 billion ...
2009 NOV 23 ... "Although much progress has been made on antipsychotic drug development, precise mechanisms behind the action of typical and atypical ...
2009 NOV 23 ... According to a study from the United States, "Switching between antipsychotic medications is common in the treatment of schizophrenia. However, data on clinical and ...
2009 NOV 23 ... criteria and long follow-up, and tried to mimic clinical routine: CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) and CUtLASS (Cost Utility of the Latest...
